ImmunoGen Inc (NASDAQ:IMGN)

8.86
Delayed Data
As of Apr 27
 -1.10 / -11.04%
Today’s Change
5.34
Today|||52-Week Range
13.78
+45.25%
Year-to-Date

Today’s Trading

Previous close9.96
Today’s open9.91
Day’s range8.80 - 9.95
Volume2,916,475
Average volume (3 months)1,677,030
Market cap$857.6M
Dividend yield--
Data as of 4:00pm ET, 04/27/2015

Growth & Valuation

Earnings growth (last year)+4.60%
Earnings growth (this year)+20.44%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+68.55%
P/E ratioNM
Price/Sales8.71
Price/Book11.30

Competitors

 Today’s
change
Today’s
% change
CHRSCoherus Biosciences ...-0.78-3.32%
OVASOvaScience Inc-2.07-6.81%
RTRXRetrophin Inc-2.01-8.12%
ANIPANI Pharmaceuticals ...-4.12-5.86%
Data as of 4:00pm ET, 04/27/2015

Financials

Next reporting dateJuly 31, 2015
EPS forecast (this quarter)-$0.29
Annual revenue (last year)$59.9M
Annual profit (last year)-$71.4M
Net profit margin-119.15%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Daniel M. Junius
Chief Financial Officer &
Executive Vice President
David B. Johnston
Corporate headquarters
Waltham, Massachusetts

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers